Sunday, April 5, 2026
Medical Specialty

Research

26 articles

Psychedelic-Assisted Therapy Shows 65% Remission Rate in Treatment-Resistant PTSD — Largest Trial to DateMental Health

Psychedelic-Assisted Therapy Shows 65% Remission Rate in Treatment-Resistant PTSD — Largest Trial to Date

Dr. Marcus ObiMar 7, 2026 · 2 min read
Gene Therapy Casgevy Produces Functional Cure in 93% of Sickle Cell Patients at 2-Year Follow-UpResearch

Gene Therapy Casgevy Produces Functional Cure in 93% of Sickle Cell Patients at 2-Year Follow-Up

Dr. Priya NairMar 6, 2026 · 2 min read
Senolytic Drugs Clear ‘Zombie Cells’ and Extend Healthspan in First Human Aging TrialResearch

Senolytic Drugs Clear ‘Zombie Cells’ and Extend Healthspan in First Human Aging Trial

Dr. Marcus ObiMar 6, 2026 · 2 min read
Wearable Continuous Glucose Monitor Predicts Type 2 Diabetes Up to 3 Years Before Diagnosis, UK Study ShowsResearch

Wearable Continuous Glucose Monitor Predicts Type 2 Diabetes Up to 3 Years Before Diagnosis, UK Study Shows

Dr. Marcus ObiMar 6, 2026 · 2 min read
AI Radiology System Detects Lung Cancer 4 Years Earlier Than Standard Screening, NHS Trial FindsOncology

AI Radiology System Detects Lung Cancer 4 Years Earlier Than Standard Screening, NHS Trial Finds

James WhitfieldMar 5, 2026 · 2 min read
Gut Microbiome Transplant Improves Insulin Sensitivity by 44% in Type 2 Diabetes Patients, Dutch Trial ShowsResearch

Gut Microbiome Transplant Improves Insulin Sensitivity by 44% in Type 2 Diabetes Patients, Dutch Trial Shows

James WhitfieldMar 4, 2026 · 2 min read
Pancreatic Cancer Survival Rates Double After New Combination Immunotherapy Approved by FDAOncology

Pancreatic Cancer Survival Rates Double After New Combination Immunotherapy Approved by FDA

James WhitfieldMar 3, 2026 · 2 min read
AI Outperforms Dermatologists in Diagnosing Melanoma From Smartphone Photos in Head-to-Head StudyOncology

AI Outperforms Dermatologists in Diagnosing Melanoma From Smartphone Photos in Head-to-Head Study

James WhitfieldFeb 28, 2026 · 2 min read
Testosterone Replacement Therapy in Men With Low Testosterone Reduces Heart Attack Risk by 17%, Trial FindsCardiology

Testosterone Replacement Therapy in Men With Low Testosterone Reduces Heart Attack Risk by 17%, Trial Finds

Dr. Marcus ObiFeb 27, 2026 · 2 min read
First Oral GLP-1 Drug Approved: Rybelsus Upgraded Formulation Shows Weight Loss Equivalent to Weekly InjectionsPharmacology

First Oral GLP-1 Drug Approved: Rybelsus Upgraded Formulation Shows Weight Loss Equivalent to Weekly Injections

Dr. Sarah ChenFeb 26, 2026 · 2 min read